SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-24-000030
Filing Date
2024-08-08
Accepted
2024-08-08 16:07:52
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20240630x10q.htm   iXBRL 10-Q 1164124
2 EX-31.1 alt-20240630xex31d1.htm EX-31.1 11931
3 EX-31.2 alt-20240630xex31d2.htm EX-31.2 11775
4 EX-32.1 alt-20240630xex32d1.htm EX-32.1 6751
5 EX-32.2 alt-20240630xex32d2.htm EX-32.2 6889
6 GRAPHIC alt-20240630x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-24-000030.txt   5057059

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20240630.xsd EX-101.SCH 34127
8 EX-101.CAL alt-20240630_cal.xml EX-101.CAL 44359
9 EX-101.DEF alt-20240630_def.xml EX-101.DEF 114639
10 EX-101.LAB alt-20240630_lab.xml EX-101.LAB 347001
11 EX-101.PRE alt-20240630_pre.xml EX-101.PRE 229156
62 EXTRACTED XBRL INSTANCE DOCUMENT alt-20240630x10q_htm.xml XML 755100
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 241188293
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)